Current and historical daily PE Ratio for ABL Diagnostics (
) from 1990 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. ABL Diagnostics stock (XPAR:ABLD) PE ratio as of Jun 09 2024 is 64.68.
More Details
ABL Diagnostics (XPAR:ABLD) PE Ratio (TTM) Chart
ABL Diagnostics (XPAR:ABLD) PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1289
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| ABL Diagnostics PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-09 | 64.7 | 2024-04-05 | 67.7 |
| 2024-06-07 | 64.7 | 2024-04-04 | 67.7 |
| 2024-06-06 | 64.7 | 2024-04-03 | 67.7 |
| 2024-06-05 | 64.7 | 2024-04-02 | 67.7 |
| 2024-06-04 | 64.7 | 2024-03-29 | 67.7 |
| 2024-06-03 | 64.7 | 2024-03-28 | 67.7 |
| 2024-05-31 | 64.7 | 2024-03-27 | 67.7 |
| 2024-05-30 | 64.7 | 2024-03-26 | 67.7 |
| 2024-05-29 | 64.7 | 2024-03-25 | 67.7 |
| 2024-05-28 | 64.7 | 2024-03-22 | 67.7 |
| 2024-05-27 | 64.7 | 2024-03-21 | 67.7 |
| 2024-05-24 | 64.7 | 2024-03-20 | 67.7 |
| 2024-05-23 | 64.7 | 2024-03-19 | 67.7 |
| 2024-05-22 | 64.7 | 2024-03-18 | 67.7 |
| 2024-05-21 | 64.7 | 2024-03-15 | 67.7 |
| 2024-05-20 | 64.7 | 2024-03-14 | 67.7 |
| 2024-05-17 | 64.7 | 2024-03-13 | 67.7 |
| 2024-05-16 | 64.3 | 2024-03-12 | 206.4 |
| 2024-05-15 | 64.7 | 2024-03-11 | 206.4 |
| 2024-05-14 | 65.1 | 2024-03-08 | 206.4 |
| 2024-05-13 | 65.1 | 2024-03-07 | 206.4 |
| 2024-05-10 | 65.1 | 2024-03-06 | 206.4 |
| 2024-05-09 | 65.1 | 2024-03-05 | 206.4 |
| 2024-05-08 | 65.1 | 2024-03-04 | 206.4 |
| 2024-05-07 | 65.1 | 2024-03-01 | 206.4 |
| 2024-05-06 | 65.1 | 2024-02-29 | 206.4 |
| 2024-05-03 | 66.8 | 2024-02-28 | 206.4 |
| 2024-05-02 | 66.0 | 2024-02-27 | 206.4 |
| 2024-04-30 | 65.1 | 2024-02-26 | 206.4 |
| 2024-04-29 | 65.1 | 2024-02-23 | 206.4 |
| 2024-04-26 | 65.1 | 2024-02-22 | 206.4 |
| 2024-04-25 | 61.7 | 2024-02-21 | 206.4 |
| 2024-04-24 | 61.7 | 2024-02-20 | 206.4 |
| 2024-04-23 | 67.7 | 2024-02-19 | 206.4 |
| 2024-04-22 | 67.7 | 2024-02-16 | 206.4 |
| 2024-04-19 | 67.7 | 2024-02-15 | 206.4 |
| 2024-04-18 | 67.7 | 2024-02-14 | 206.4 |
| 2024-04-17 | 67.7 | 2024-02-13 | 206.4 |
| 2024-04-16 | 67.7 | 2024-02-12 | 206.4 |
| 2024-04-15 | 67.7 | 2024-02-09 | 206.4 |
| 2024-04-12 | 67.7 | 2024-02-08 | 206.4 |
| 2024-04-11 | 67.7 | 2024-02-07 | 206.4 |
| 2024-04-10 | 67.7 | 2024-02-06 | 206.4 |
| 2024-04-09 | 67.7 | 2024-02-05 | 206.4 |
| 2024-04-08 | 67.7 | 2024-02-02 | 206.4 |
ABL Diagnostics (XPAR:ABLD) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
ABL Diagnostics
SIC : 6211
ISIN : FR001400AHX6
Compare
Compare
Traded in other countries / regions
ABLD.France9BK0.Germany0OPO.UK IPO Date
1989-07-27Description
ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers